Rozetta Co., Ltd. is a Japanese AI company with a track record of adoption by more than 6,000 companies in the field of AI automatic translation. Utilizing its technical capabilities, the company provides highly specialized closed generative AI development tailored to corporate needs, supporting business efficiency and the promotion of DX.
[Positioning and Track Record] Rozetta positions itself as "a specialized AI company focused on translation, pharmaceuticals, and finance," emphasizing its track record of 2,000 domains and 6,000 companies, and advocating "AI that understands the industry, customized for each client." The source cited is ITR Market View: AI Business Support and Recognition Market 2026, and in the translation market, the company claims to have held the No. 1 share in Japan for five consecutive years from fiscal 2021 to fiscal 2025. The company is also a core operating company of the Tokyo Stock Exchange Growth Market-listed "Metareal (6182)" group, continuously discloses management and financial information, and has obtained Information Security Management System (ISMS) certification, covering stages such as sales proposals, design and construction, operation, maintenance, and support.
[Main Capabilities and Products] The company provides a variety of specialized AI products and also broadly offers individual support for specialized fields not listed:
- MetaRozetta: A new brand born from the evolution of (former) T-4OO, it is an industrial translation AI that has held the No. 1 share in Japan for five consecutive years, claims a revision requirement rate of 0.003%, and achieves "fully automatic translation."
- Real-time text conversion and translation tool: It can convert and translate speech from web conferences or videos into text in real time; in meetings conducted in Japanese with Japanese, it can also be used as a minutes creation tool.
- Pharmaceutical domain AI: Automatically reviews the consistency of vast content such as documents and papers; it covers everything from document creation to knowledge retrieval, and adoption in pharmaceutical companies is progressing.
- Corporate analysis dialogue tool: Co-developed with Toyo Keizai Inc., it supports corporate analysis in dialogue form using articles and data such as "Company Quarterly Report Online" as sources.
- Content localization AI: Accelerates localization of games and other content with translation that reflects character personality, tone, and emotion.
[How to Use] The materials mention that one can start with a document request or consultation, and the company will propose the optimal solution according to the client's issues; service introduction materials and case studies can be viewed immediately; consultations, quotations, and demo requests are also possible. Specific product installation, integration, or operating steps are not provided at this time.
[Applicable Scenarios] It is suitable for corporate business efficiency and DX promotion, industrial translation, meeting minutes creation, real-time translation of videos and web conferences, pharmaceutical document consistency review and knowledge retrieval, corporate analysis, localization of games and other content, and customer-specific closed generative AI development, among othersScenarios.
[Limitations] The materials do not provide detailed information such as specific fee structures, prices, the number of supported languages, systems to integrate with, deployment methods, or free trial conditions, and no related explanation is provided at this time.
